✦ LIBER ✦

Safety and tolerability of avagacestat (BMS-708163) in people with predementia Alzheimer's disease: Association with nonmelanoma skin cancer

✍ Scribed by Preston, Jeanette; Berman, Robert; Kaplita, Stephen; Gandhi, Kunal K.; Lipschitz, Alan; Tiller, Jane; Yogendran, Logesvaran; Hodson, Darryl S.; Coric, Vlad

Book ID: 123189557
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 79 KB
Volume: 9
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2013.05.566

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Occurrence of nonmelanoma skin cancer in

Occurrence of nonmelanoma skin cancer in the elderly with and without Alzheimer's Disease in the US

✍ Jasmanda Wu; Zhenchao Guo; Robert Berman; Vlad Coric; Sandeep Kumar; Maha Radhak 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Efficacy, safety and tolerability of a h

Efficacy, safety and tolerability of a higher-dose 13.3 mg/24 h rivastigmine patch in people with severe Alzheimer's disease with and without concomitant memantine use

✍ Grossberg, George; Farlow, Martin; Meng, Xiangyi; Somogyi, Monique 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Effect of body mass index on the efficac

Effect of body mass index on the efficacy, safety and tolerability of a higher-dose 13.3 mg/24 h rivastigmine patch in people with severe Alzheimer's disease

✍ Sadowsky, Carl; Somogyi, Monique; Frolich, Lutz; Meng, Xiangyi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

A 24-week, open-label extension to the A

A 24-week, open-label extension to the ACTivities of daily living and cognitION (ACTION) study: Long-term safety, tolerability and efficacy of a 13.3 mg/24 h rivastigmine patch in people with severe Alzheimer's disease

✍ Farlow, Martin; Grossberg, George; Sadowsky, Carl; Meng, Xiangyi; Somogyi, Moniq 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 51 KB